What Fulgent Genetics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 4 | 15 |
| Total trades | 8 | 84 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 441,317 |
| Disposed | 16,528 | 278,599 |
| Net activity | −16,528 | +162,718 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Gao Hanlin | Chief Scientific Officer | Sep 02 | Sale for tax withholding · S | −1,673 | $19.66 | −$32.9K | 986,117 |
| Xie Jian | President and COO | Sep 02 | Sale for tax withholding · S | −2,127 | $19.66 | −$41.8K | 359,924 |
| Hsieh Ming | Chief Executive Officer | Sep 01 | Withheld — tax / exercise cost · F | −4,392 | $19.59 | −$86K | 885,952 |
| Kim Paul | CFO and Treasurer | Sep 01 | Withheld — tax / exercise cost · F | −2,087 | $19.59 | −$40.9K | 356,543 |
| Xie Jian | President and COO | Aug 27 | Sale for tax withholding · S | −1,193 | $19.91 | −$23.7K | 362,051 |
| Gao Hanlin | Chief Scientific Officer | Aug 27 | Sale for tax withholding · S | −939 | $19.91 | −$18.7K | 987,790 |
| Hsieh Ming | Chief Executive Officer | Aug 26 | Withheld — tax / exercise cost · F | −2,949 | $19.81 | −$58.4K | 890,344 |
| Kim Paul | CFO and Treasurer | Aug 26 | Withheld — tax / exercise cost · F | −1,168 | $19.81 | −$23.1K | 358,630 |
| Gao Hanlin | Chief Scientific Officer | Jul 26 | Withheld — tax / exercise cost · F | −1,645 | $19.67 | −$32.4K | 988,729 |
| Xie Jian | President and COO | Jul 26 | Withheld — tax / exercise cost · F | −4,361 | $19.67 | −$85.8K | 363,244 |
| Kim Paul | CFO and Treasurer | Jul 26 | Withheld — tax / exercise cost · F | −2,747 | $19.67 | −$54K | 359,798 |
| Gao Hanlin | Chief Scientific Officer | Jun 02 | Sale for tax withholding · S | −1,688 | $17.89 | −$30.2K | 990,374 |
| Xie Jian | President and COO | Jun 02 | Sale for tax withholding · S | −2,146 | $17.89 | −$38.4K | 367,605 |
| Hsieh Ming | Chief Executive Officer | Jun 01 | Withheld — tax / exercise cost · F | −4,392 | $18.09 | −$79.5K | 893,293 |
| Kim Paul | CFO and Treasurer | Jun 01 | Withheld — tax / exercise cost · F | −2,087 | $18.09 | −$37.8K | 362,545 |
| Gao Hanlin | Chief Scientific Officer | May 27 | Sale for tax withholding · S | −945 | $17.60 | −$16.6K | 992,062 |
| Xie Jian | President and COO | May 27 | Sale for tax withholding · S | −1,201 | $17.60 | −$21.1K | 369,751 |
| Hsieh Ming | Chief Executive Officer | May 26 | Withheld — tax / exercise cost · F | −2,949 | $17.67 | −$52.1K | 897,685 |
| Kim Paul | CFO and Treasurer | May 26 | Withheld — tax / exercise cost · F | −1,168 | $17.67 | −$20.6K | 364,632 |
| Nohaile Michael | Director | May 14 | Grant / award · A | +5,558 | — | — | 24,578 |
Loading...
